EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

02.11.18

Pharma Patents Have Become Harder to Enforce, So IAM Together With the Patent Microcosm Sets Up Lobbying Events

Posted in America, Deception, Europe, Patents at 9:31 am by Dr. Roy Schestowitz

IAM: When “alternative facts” are up for sale (if one can afford them)

Battistelli and IAM

Summary: The difficulty associated with enforcing certain types of patents (more so after Mayo and § 101) means that litigious attitudes and reliance on law firms are decreasing; IAM strikes back with another one of its many lobbying events (designed to shape public opinion and influence key decision-makers)

THE concept of patents is pretty much universal, but not all patents are created equal. There are different sorts of patents (“families”) pertaining to or belonging to different domains. Speaking of them all as though they’re the same is the recipe for meaningless debates. Not all patents, for example, are a matter of life or death. Ethical aspects apply in some cases; sometimes pure economics.

“Not all patents, for example, are a matter of life or death.”As we discovered quite recently, EPO oppositions can crash companies. In other words, wrong decisions (or intentions) to grant can be truly harmful and pretty awful to workers. Things get pretty freaky when patents are being claimed on life itself. Forward Pharma lost 30% of its value (or valuation) in just one day at the end of January. This was due to an EPO decision. Yes, some sectors are over-reliant on patents; there’s no question about it. Here’s an example from two days ago: (in the UK)

Shares in Scancell Holdings PLC rose sharply on Friday morning as the company said its Moditope immunotherapy platform is to be granted a European patent.

Scancell shares were up 11% on Friday at 13.54 pence per share.

How good is this European Patent (EP)? Well, there’s lack of certainty under Battistelli, so Scancell Holdings PLC might be the next Forward Pharma (a one-day collapse).

“What we have here is a cross-continental fight taken up to the ITC and failing, having heavily relied on a patent from the USPTO.”Pacific Biosciences is meanwhile attempting to ‘compete’ by causing embargo of its rival, Oxford Nanopore. We wrote about it some days ago and received plenty of comments from people involved in this matter. It’s yet another one of those ITC examples where patent litigation is geared towards embargoes and bankruptcies, not innovation. Here is what the face-saving press release said (striving to justify waste of shareholders’ money, spent on litigation). This campaign of patent litigation by Pacific Biosciences backfired pretty badly. “Pacific Bio down 2% premarket on ITC patent ruling,” Wall Street media stated shortly thereafter. To quote: “The ITC interpreted the term “single-molecule sequencing” as limited to sequencing-by-synthesis approaches, determining that Oxford’s sequencing approach is not “single-molecule sequencing.””

What we have here is a cross-continental fight taken up to the ITC and failing, having heavily relied on a patent from the USPTO.

We have become increasingly supportive of the USPTO because it continues to deny patents on life and even software patents. PTAB helps and gravitates towards that. See the latest PTAB Life Sciences Report by John Cravero and Pharma Patents Blog writing about 35 U.S.C. § 101 rejections (not just based on Alice but also Mayo):

We’ve written previously about ex parte decisions of the Patent Trial and Appeal Board (PTAB) affirming patent eligibility rejections that seem to be inconsistent with the USPTO’s Subject Matter Eligibility Guidance. Apparently, applicants should be wary about appealing any rejection of a diagnostic method claim, because the PTAB may enter sua sponte patent eligibility rejections even if the examiner did not make a § 101 rejection.

Aside from § 101 there’s also 35 U.S.C. § 102. Hospira, based on this blog post, wins again. MedCo’s patent has been declared bogus as per § 102. To quote:

In the litigation, Hospira argued both (1) that the MedCo patents were invalid and (1) that Hospira’s proposed generic Angiomax drug would not infringe. The district court sided with MedCo on the first point (patents not invalid) but with Hospira on the second (patents not infringed). On appeal, the Federal Circuit has affirmed the non-infringement ruling but reversed on the on sale issue. The interesting portion is the on sale question.

Benjamin Anger and Jacob R. Rosenbaum wrote about it some days ago (very detailed).

“They get what they paid for. It’s pure lobbying/marketing.”As one can expect, the litigation ‘industry’ isn’t particularly happy about that. Many patents are being invalidated, which must be causing decrease in demand for patents and lawsuits (their main “offerings” or “services” or “products”).

There’s a “Pharma and Biotech IP Summit” being organised by IAM and as one can expect, the bill for this lobbying event is being footed by the main participants. “Finnegan is a Gold sponsor of IAM Magazine,” it says. There’s therefore a paid-for ‘talk’ (marketing). This not only helps Finnegan control the ‘debate’; it also keeps IAM on their ‘good side’ (maybe IAM will give Finnegan some more of these bogus ‘rewards’ or ‘endorsements’). “Jen Roscetti will present “The View from the United States” at @IAM_magazine’s #Pharma and #Biotech #IP Summit in London,” Finnegan wrote the other day. They get what they paid for. It’s pure lobbying/marketing.

“Either way, “Pharma and Biotech IP Summit” is an IAM sham. It’s sponsored by and dominated by the patent microcosm.”With all honesty, more people ought to speak out about IAM’s “business model”, which involves collecting cash, pushing agenda (in the form of ‘news’ or staged ‘debates’), offering bogus ‘endorsements’, and issuing 'studies' for people like Battistelli (bolstering his lies). There’s nothing benign about it. IAM is effectively a think tank and even some less senior insiders must have realise it. Several of them left, only to be replaced by relatively young and inexperienced writers. Tim Lince, it should be noted, is still listed as a writer at IAM, but he wrote nothing this year and only 1 (one!) blog post last year. Many writers left and perhaps associating with people Battistelli (as we last noted last night) won’t save them but only cause further harm.

Either way, “Pharma and Biotech IP Summit” is an IAM sham. It’s sponsored by and dominated by the patent microcosm. It’s like a propaganda platform facilitated by Joff Wild and his cohorts. He did the same for UPC (with cash from the EPO’s PR firm).

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 18/2/2020: Linux 5.6 RC2, Wine 5.2, GNU Social Contract and Sparky 2020.02 Special Editions

    Links for the day



  2. IRC Proceedings: Sunday, February 16, 2020

    IRC logs for Sunday, February 16, 2020



  3. Links 16/2/2020: MX Linux 19.1 and MyPaint 2.0

    Links for the day



  4. IRC Proceedings: Saturday, February 15, 2020

    IRC logs for Saturday, February 15, 2020



  5. Guest Article: Au Revoir, GNU/Linux

    "Funny how OSI just ended up being another vehicle for their takeover of the computing world..."



  6. Former Microsoft Employee: ZDNet is Owned by Microsoft (and Others) in Some Senses

    A noteworthy message we've received from someone who knows Microsoft from the inside



  7. Links 15/2/2020: Blender 2.82, Qt 5.15 Alpha and NetBSD 9.0 Released

    Links for the day



  8. Microsoft Views 'Open Source' as a Zero-Cost Heist Opportunity (Making Proprietary Software/Spyware Using Other People's Free Labour)

    Making GPL-licensed (copyleft) software and hosting it outside Microsoft’s jaws is the best way to counter the abusive monopolist, which still says it “loves” what it is actually attacking



  9. Did Microsoft 'Buy' ZDNet?

    A look at what ZDNet tells its readers (screenshot from this morning) and a rare look at how its writers are censored/suppressed



  10. Anatomy of a Crime and Protection From Prosecution

    It’s hard to forget what António Campinos hides for his friend



  11. Today's EPO is a Fraud Managed by Frauds

    Beneath the scandals associated with systematic abuse against staff, union-busting (silencing whistleblowers) and en masse granting of invalid patents — the hallmark of grotesque maladministration — lie a bunch of even greater crimes



  12. IRC Proceedings: Friday, February 14, 2020

    IRC logs for Friday, February 14, 2020



  13. One Need Only Look at ZDNet's 'Linux' Section to Understand It's a Microsoft Propaganda Operation

    A timely new snapshot (or screenshot) that demonstrates what ZDNet became after hiring Microsoft employees as ‘journalists’ and censoring on behalf of Microsoft, defaming Free software figures and so on



  14. Links 14/2/2020: New Release of KStars, OpenSSH 8.2, Rhythmbox 3.4.4, Flatpak 1.6.2

    Links for the day



  15. The Uselessness of Social Control Media and Why We Need RSS Feeds' Resurgence More Than Ever

    Social control media became pure noise or misinformation, usually in pursuit of financial expansion alone, and it is also a censorship machine which discourages not falsehoods but unconventional thinking



  16. Another New 'Clown' for the UPC 'Circus'

    A former writer of IPPro Magazine (which seems to be defunct now) reports another shuffle -- perhaps the fifth in a few years -- of "IP" [sic] Minister for the UK; it doesn't bode well for the Unified Patent Court (UPC)



  17. IRC Proceedings: Thursday, February 13, 2020

    IRC logs for Thursday, February 13, 2020



  18. Links 13/2/2020: Ubuntu 18.04.4 LTS, Septor 2020, Endless OS 3.7.7, Wayland 1.18.0, KDE Plasma 5.18 and GTK 3.98 Released

    Links for the day



  19. The Microsoft Propaganda Model

    Classic new examples (real screenshots) of how Microsoft-funded media entraps people looking for information about "Linux" to actually push Microsoft talking points and marketing, cover-up, face-saving lies etc.



  20. What's Evil is Forcing People to Use Something They Don't Want and Typically Dislike

    The difference between Google Search and Microsoft is that many people actually want to use Google (and don't have to)



  21. 2020: The Year Microsoft Became Honest... About Being Corrupt and Criminal

    Microsoft is destroying any past attempts to portray itself as a reformed company or 'recovering criminal'; nothing is really changing and everyone has noticed



  22. Free Software is Being Abandoned by Opponents of Software Patents and It's Being Attacked by Patent Trolls

    The Electronic Frontier Foundation (EFF) is rotting away as an advocate against software patents; Patents on algorithms are still being granted (even when courts repeatedly reject these) and Red Hat's Chief Patent Counsel remains Manny Schecter, one of the loudest proponents of such patents (citing the likes of Adam Mossoff this week, in effect Koch operatives); this is a very big problem because Free software projects come under a barrage of lawsuits, using patents like those IBM lobbies ferociously to legitimise



  23. IRC Proceedings: Wednesday, February 12, 2020

    IRC logs for Wednesday, February 12, 2020



  24. Links 12/2/2020: KDE Neon 5.18, Tails 4.3 and WordPress 5.4 Beta

    Links for the day



  25. IRC Proceedings: Tuesday, February 11, 2020

    IRC logs for Tuesday, February 11, 2020



  26. Links 11/2/2020: New Firefox and KDE Plasma

    Links for the day



  27. Sometimes ILO-AT is Good for Nothing But Law Firms in or Around Switzerland

    ILO-AT’s latest judgements are out. But ILO — and by extension the UN — are still morally deficient and they give the impression that don’t care about people (or that ILO is in bed with the same businesses WIPO (UN) serves, i.e. no better than WB/IMF).



  28. The European Patent Office Continues to Violate the European Patent Convention (EPC) With Impunity While the European Commission Lets That Happen

    The European Commission (and Union) can be seen as increasingly complicit in the EPO's abuses; this means that the EPO has become a liability or source of accountability for the integrity of Europe as a bloc



  29. IRC Proceedings: Monday, February 10, 2020

    IRC logs for Monday, February 10, 2020



  30. EPO Staff Representatives to Challenge Ridiculous and Unnecessary Austerity Measures

    The EPO's President of Nepotism "is currently finalizing his “package” of financial measures in order to reduce an alleged coverage gap of 5.8 B€ following a heavily biased and flawed Financial Study," according to EPO staff representatives who have already demonstrated it's a fake crisis that distracts from the real crisis and profound corruption


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts